Enclomiphene

Description

What is Enclomiphene Citrate?

Enclomiphene citrate is a synthetic nonsteroidal selective estrogen receptor modulator (SERM) and the trans-isomer of clomiphene citrate. It is classified as an estrogen receptor antagonist with activity primarily studied within the hypothalamic–pituitary–gonadal (HPG) axis. Unlike mixed-isomer clomiphene preparations, enclomiphene represents the isolated trans-isomer component and has been investigated for its effects on endogenous gonadotropin and testosterone regulation.

The primary mechanism investigated for enclomiphene citrate involves antagonism of estrogen receptors in hypothalamic and pituitary tissues. By reducing estrogen-mediated negative feedback signaling, enclomiphene may influence the release of gonadotropins, including luteinizing hormone (LH) and follicle-stimulating hormone (FSH). These hormones are involved in regulating testicular testosterone production and spermatogenesis.

Studies have investigated enclomiphene citrate in men with secondary hypogonadism, where impaired signaling within the HPG axis contributes to reduced testosterone production. Research suggests that enclomiphene may increase endogenous testosterone production while maintaining gonadotropin signaling, although outcomes depend on individual endocrine function and the presence of a functional hypothalamic–pituitary–testicular axis.

Product Specifications

• Compound / Peptide name: Enclomiphene citrate
• Classification: Selective estrogen receptor modulator (SERM); nonsteroidal estrogen receptor antagonist
• Sequence: Not applicable
• Molecular Formula: C₃₂H₃₆ClNO₈
• Molecular Weight: 598.08 g/mol (enclomiphene citrate salt)
• CAS Number: 7599-31-9
• PubChem CID: 59692
• Form: Tablets
• Strength: 12.5 mg/tablet
• Purity: >99% (as provided)
• Appearance: Liquid formulation; specific appearance not provided
• Storage: Store according to supplier specifications
• Regulatory Status: Investigational compound; not approved as a general-purpose hormone optimization supplement

What Is It Used For and Its Purpose 

Enclomiphene citrate is primarily studied in endocrinology research focused on male reproductive hormone regulation, particularly conditions involving reduced endogenous testosterone production associated with secondary hypogonadism. Researchers investigate its ability to influence hormonal signaling while preserving activity of the reproductive axis.

The compound is of interest because it acts through central endocrine pathways rather than directly supplying external testosterone. Research has examined whether modulation of estrogen receptor signaling can affect LH and FSH secretion, testosterone production, and reproductive hormone parameters. Clinical investigations have explored enclomiphene citrate in men with secondary hypogonadism, including studies assessing testosterone concentrations and sperm-related outcomes.

Potential research applications include:

• Endocrinology and hormone regulation
• Hypothalamic–pituitary–gonadal axis research
• Estrogen receptor signaling studies
• Male reproductive biology
• Testosterone biosynthesis research
• Spermatogenesis and fertility-related investigations

Potential Scientific Benefits 

Enclomiphene citrate has been investigated for its ability to modulate estrogen receptor signaling within the hypothalamic–pituitary axis. By reducing estrogen-mediated negative feedback, the compound may increase gonadotropin signaling, which can influence endogenous testosterone production in appropriate biological models.

Clinical Studies have examined enclomiphene citrate in men with secondary hypogonadism. Some studies have reported increases in serum testosterone concentrations and maintenance of sperm parameters compared with exogenous testosterone approaches. The biological activity of enclomiphene depends on intact endocrine signaling pathways. Individuals with primary testicular dysfunction may not respond in the same manner because the mechanism requires functional communication between the hypothalamus, pituitary gland, and testes.

Research has also examined the pharmacological differences between enclomiphene and other clomiphene-related compounds. As a selective isomer, enclomiphene provides a model for studying estrogen receptor modulation without the additional activity associated with other stereoisomers.

Reported research findings and mechanisms include:

• Antagonism of estrogen receptor signaling in hypothalamic and pituitary pathways
• Modulation of LH and FSH secretion in endocrine research models
• Investigation of endogenous testosterone production pathways
• Study of male reproductive hormone regulation
• Evaluation of sperm parameter preservation compared with testosterone replacement approaches
• Investigation of HPG-axis feedback mechanisms

Current evidence remains limited, and further well-controlled clinical studies are required to establish long-term efficacy and safety in humans.

Research Data Sheet 

• Compound / Peptide name: Enclomiphene citrate
• Sequence: Not applicable
• Classification: Selective estrogen receptor modulator (SERM)
• Molecular Formula: C₃₂H₃₆ClNO₈
• Molecular Weight: 598.08 g/mol
• CAS Number: 7599-31-9
• PubChem CID: 59692
• Purity: >99%
• Storage: Store according to supplier specifications
• Research Categories: Endocrinology; estrogen receptor signaling; testosterone regulation; male reproductive biology; hypothalamic–pituitary–gonadal axis research

Safety Precautions 

Enclomiphene citrate is supplied strictly for laboratory research use and should only be handled by qualified professionals following appropriate chemical safety procedures. Hormone-modulating compounds require careful documentation and controlled handling because endocrine pathways involve complex systemic interactions.

• Research use only
• Not for human consumption
• Not intended to diagnose, treat, or prevent disease
• Use appropriate PPE, including gloves, laboratory coat, and eye protection
• Follow appropriate handling and laboratory hygiene procedures
• Maintain proper storage conditions according to supplier recommendations
• Avoid freeze–thaw cycles where applicable
• Ensure proper labeling and documentation of research materials
• Dispose of waste according to applicable laboratory regulations
• Limited long-term human safety data are available
• Potential unknown endocrine effects require further investigation

Conclusion 

Enclomiphene citrate is an investigational selective estrogen receptor modulator studied for its role in endocrine regulation, particularly within the hypothalamic–pituitary–gonadal axis. Its mechanism of action provides researchers with a model for examining how estrogen receptor signaling influences reproductive hormone regulation.

Research studies have evaluated enclomiphene citrate in relation to endogenous testosterone production, gonadotropin signaling, and male reproductive parameters. The compound remains relevant to biomedical research involving hormone signaling, reproductive endocrinology, and molecular pharmacology. Its effects depend on biological context, endocrine function, and experimental conditions. Enclomiphene citrate should be considered a research compound intended for controlled scientific investigation rather than a general hormone optimization product.